Skip to content
HowShorted

Editas Medicine, Inc. short interest in 2026

In 2026, Editas Medicine, Inc.'s disclosed short interest ran from 12.12% of shares outstanding on 15 Jan 2026 to 19.51% on 15 Sep 2026, a change of +7.39 percentage points. The year's high was 22.95% on 30 Jun 2026 and its low 9.77% on 15 May 2026, averaging 14.92% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.19 days on 31 Jul 2026. Full history: Editas Medicine, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Editas Medicine, Inc. in 2026

2026 in figures

Start of year
12.12% (15 Jan 2026)
End of year
19.51% (15 Sep 2026)
Change
+7.39 pp
High
22.95% (30 Jun 2026)
Low
9.77% (15 May 2026)
Average
14.92%
Highest days to cover
18.19 (31 Jul 2026)
SEC filings marked
6

Every report in 2026

Editas Medicine, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202612.12%6.04
30 Jan 202611.74%6.11
13 Feb 202612.03%7.99
27 Feb 202612.18%8.20
13 Mar 202611.80%5.0710-K filed, results (8-K)
31 Mar 202612.23%8.62
15 Apr 202611.18%6.48
30 Apr 202610.22%7.07
15 May 20269.77%8.5610-Q filed, results (8-K)
29 May 202615.39%3.36
15 Jun 202618.81%7.70
30 Jun 202622.95%7.21
15 Jul 202622.67%8.02
31 Jul 202615.28%18.19
14 Aug 202616.07%14.5910-Q filed, results (8-K)
31 Aug 202619.69%8.96
15 Sep 202619.51%15.72

See also: Editas Medicine, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.